BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4363071)

  • 21. Cushing's syndrome in women with polycystic ovaries and hyperandrogenism.
    Fegan PG; Sandeman DD; Krone N; Bosman D; Wood PJ; Stewart PM; Hanley NA
    Nat Clin Pract Endocrinol Metab; 2007 Nov; 3(11):778-83. PubMed ID: 17955019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressibility of plasma adrenocorticotropin by hydrocortisone: potential usefulness in the diagnosis of Cushing's disease.
    Streeten DH; Anderson GH; Brennan S; Jones C
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1114-20. PubMed ID: 9543127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated levels of adrenocorticotropin (ACTH) precursors in post-adrenalectomy Cushing's disease and their regulation by glucocorticoids.
    Ray DW; Gibson S; Crosby SR; Davies D; Davis JR; White A
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2430-6. PubMed ID: 7629238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remission of acanthosis nigricans associated with polycystic ovarian disease and a stromal luteoma.
    Givens JR; Kerber IJ; Wiser WL; Andersen RN; Coleman SA; Fish SA
    J Clin Endocrinol Metab; 1974 Mar; 38(3):347-55. PubMed ID: 4360917
    [No Abstract]   [Full Text] [Related]  

  • 25. [The problem of hirsutism in the light of modern acquisitions in steroid physiopathology].
    Conti C
    Folia Endocrinol; 1968 Oct; 21(5):529-58. PubMed ID: 5756725
    [No Abstract]   [Full Text] [Related]  

  • 26. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.
    Pieters GF; Smals AG; Goverde HJ; Pesman GJ; Meyer E; Kloppenborg PW
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1188-97. PubMed ID: 6290524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Levels of corticotropin, cortisol, gonadotropic hormones, prolactin and sex steroids in women suffering from Itsenko-Cushing disease].
    Komissarenko IV; Veĭnberg EG; Manusharova RA; Cheban AK; Slavnov VN
    Vrach Delo; 1985 Jul; (7):51-4. PubMed ID: 2996233
    [No Abstract]   [Full Text] [Related]  

  • 28. [Description of a case of Cushing's syndrome with development of Nelson's syndrome].
    Tamborino G; Galli V; Gatti G; Massolo F
    Minerva Pediatr; 1976 Jun; 28(21):1376-9. PubMed ID: 948340
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of serum prostate-specific antigen concentrations in women with Cushing's disease.
    Libé R; Barbetta L; Dall'Asta C; Beck-Peccoz P; Ambrosi B
    Horm Metab Res; 2003 May; 35(5):330-2. PubMed ID: 12916005
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
    Allolio B; Winkelmann W; Hipp FX; Kaulen D; Mies R
    J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels.
    Lado-Abeal J; Rodriguez-Arnao J; Newell-Price JD; Perry LA; Grossman AB; Besser GM; Trainer PJ
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3083-8. PubMed ID: 9745407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sertoli-Leydig cell tumor of the ovary, with an associated mucinous cystadenoma. An ultrastructural and endocrine study.
    Roth LM; Cleary RE; Rosenfield RL
    Lab Invest; 1974 Dec; 31(6):648-57. PubMed ID: 4280005
    [No Abstract]   [Full Text] [Related]  

  • 34. Malignant ovarian Sertoli-Leydig cell tumor localized with selective ovarian vein sampling.
    Dunne C; Havelock JC
    J Minim Invasive Gynecol; 2012; 19(6):789-93. PubMed ID: 23084689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myopathy associated with pigmentation following adrenalectomy for Cushing's syndrome.
    Prineas J; Hall R; Barwick DD; Watson AJ
    Q J Med; 1968 Jan; 37(145):63-77. PubMed ID: 4297955
    [No Abstract]   [Full Text] [Related]  

  • 36. Longitudinal banded pigmentation of nails following adrenalectomy for cushing's syndrome.
    Bondy PK; Harwick HJ
    N Engl J Med; 1969 Nov; 281(19):1056-7. PubMed ID: 4310034
    [No Abstract]   [Full Text] [Related]  

  • 37. [Test of pituitary adrenal restraining with IV dexamethasone in the diagnosis of Cushing's syndrome (author's transl)].
    Linquette M; Cappoen JP; Fourlinnie JC; Harpignies G
    Sem Hop; 1980 Sep 18-25; 56(33-36):1380-4. PubMed ID: 6252630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of pituitary Cushing's disease: results of adrenal and pituitary surgery.
    Pelkonen R; Eistola P; Grahne B; Kuusisto A; Paetau A; Sivula A; Valtonen S
    Acta Endocrinol Suppl (Copenh); 1983; 251():38-46. PubMed ID: 6301188
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cushing's syndrome with pigmentation. (II)].
    Bricaire H; Luton JP; Laurent M
    Presse Med (1893); 1967 Dec; 75(55):2821-4. PubMed ID: 4296286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.